[ad_1]
WCG FDANews
FALLS CHURCH, Va. (PRWEB)
June 02, 2020
Dealing with FCPA and Other Investigations Under the New Normal
An FDAnews Webinar
Tuesday, June 16, 2020, 1:30 p.m.-3:00 p.m. EDT
https://www.fdanews.com/dealingwithfcpa
Maintaining compliance under the Foreign Corrupt Practices Act of 1977 (FCPA) and other related regulations can be a challenge during typical economic times, and even more difficult during the COVID-19 crisis. Navigating these complications without relying on actions that may deemed uncompliant is as important as ever.
How does one safely mitigate risks during this trying period while averting investigations from regulatory bodies?
Gail Rodgers and Nancy Sims, attorneys with DLA Piper, will share practical guidelines and tips on maintaining compliance, while also discussing how to manage any potential investigations from regulatory bodies:
-
Identifying Concerns and Risk
a. Remote workforce
b. Reopening business
- Finding Risk Mitigation Strategies
a. Compensating for disrupted controls
- Developing Investigation Protocols
a. Remote working procedures
b. Alternative working arrangement processes
- Implementing Audit Methods
a. “Pressure testing” for compliance
b. Remote financial controls
- Prioritizing Investigation and Compliance Tasks
a. Applying a risk-based approach
The COVID-19 crisis has brought extraordinary strains to business practices and compliant supply chains. Ensure one’s organization is protected before and during an investigation.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
Dealing with FCPA and Other Investigations Under the New Normal
An FDAnews Webinar
Tuesday, June 16, 2020, 1:30 p.m.-3:00 p.m. EDT
https://www.fdanews.com/dealingwithfcpa
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/dealingwithfcpa
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations
Share article on social media or email:
[ad_2]